Three December decisions from the Court Of Justice of the European Union shed light on supplementary protection certificates in Europe.
Georgetown University v Octroocentrum Nederland (Netherlands Patent Office)
Background
In 2007, Georgetown University filed eight SPC applications with the Netherlands Patent Office (OCN) based on European patent number 0647140 entitled ‘Papillomavirus vaccine’. The patent was awarded on December 12, 2007 (the day of the SPC application) and expired on June 23, 2013. Two of the SPC applications covered combinations of the active ingredients of the vaccine, four were for the individual active ingredients, and two others related to two of the individual ingredients.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
SPCs, CJEU, supplementary protection certificates, Sanofi, Georgetown